NEW YORK – Insiders said late last week that Pfizer will name CME-KHBB/Minneapolis the agency for its new $10-million Reactine antihistamine business. Also, the company may give Tatham Euro RSCG an undisclosed product as a result of the pitch for the Reactine account. Neither agency would comment. Both agencies were finalists for the Reactine business.
Copyright Adweek L.P. (1993)